Al Ghobain M, Farahat F, Zeitouni M, Alsowayan W, Al-Awfi S, AlBarrak A
Ann Thorac Med. 2025; 20(1):36-48.
PMID: 39926401
PMC: 11804953.
DOI: 10.4103/atm.atm_202_24.
Al-Jahdali H, Al-Lehebi R, Lababidi H, Alhejaili F, Habis Y, Alsowayan W
Ann Thorac Med. 2025; 20(1):1-35.
PMID: 39926399
PMC: 11804957.
DOI: 10.4103/atm.atm_155_24.
Qiyuan P, Changyang L, Gaigai L, Ju Q, Xun Z
PLoS One. 2025; 19(12):e0312099.
PMID: 39774531
PMC: 11684632.
DOI: 10.1371/journal.pone.0312099.
Jiao X, Zhang Y, Kuang T, Gong J, Yuan Y, Zhen G
Int J Cardiol Heart Vasc. 2024; 55:101533.
PMID: 39624152
PMC: 11609479.
DOI: 10.1016/j.ijcha.2024.101533.
Robertoni F, Velosa A, Oliveira L, de Almeida F, da Silveira L, Queiroz Z
Front Immunol. 2024; 15:1444622.
PMID: 39301030
PMC: 11410637.
DOI: 10.3389/fimmu.2024.1444622.
The clinical characteristics associated with the ratio between the main pulmonary artery and ascending aorta diameter in patients with acute exacerbation of chronic obstructive pulmonary disease.
Lee J, Kho B, Yoon J, Yoon C, Na Y, Park H
J Thorac Dis. 2024; 16(8):4924-4934.
PMID: 39268104
PMC: 11388226.
DOI: 10.21037/jtd-24-62.
Remote Patient Monitoring and Machine Learning in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Dual Systematic Literature Review and Narrative Synthesis.
Glyde H, Morgan C, Wilkinson T, Nabney I, Dodd J
J Med Internet Res. 2024; 26:e52143.
PMID: 39250789
PMC: 11420610.
DOI: 10.2196/52143.
Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy.
Kaplan A, Babineau A, Hauptman R, Levitz S, Lin P, Yang M
Front Med (Lausanne). 2024; 11:1416163.
PMID: 39165372
PMC: 11333456.
DOI: 10.3389/fmed.2024.1416163.
Survival benefit of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a nationwide cohort study.
Shin J, Park S, Lee J, Lee J
Sci Rep. 2024; 14(1):14703.
PMID: 38926519
PMC: 11208440.
DOI: 10.1038/s41598-024-65763-1.
A comparison of two weaning strategies for non-invasive ventilation in chronic obstructive pulmonary disease patients with acute respiratory failure.
Sadanandan A, George S, Mohamed Nambipunnilath S, Puthiyaveettil S
Ir J Med Sci. 2024; 193(5):2419-2425.
PMID: 38789666
DOI: 10.1007/s11845-024-03724-3.
Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study.
Athanazio R, Bernal Villada L, Avdeev S, Wang H, Ramirez-Venegas A, Sivori M
BMJ Open Respir Res. 2024; 11(1).
PMID: 38637115
PMC: 11029392.
DOI: 10.1136/bmjresp-2023-002101.
Exploring the impact of OSA on short-term survival in patients with AECOPD admitted to the ICU.
Liu L, Chen Y, He G, Lin B, Zhu Z, Wei R
PLoS One. 2024; 19(4):e0301646.
PMID: 38603665
PMC: 11008870.
DOI: 10.1371/journal.pone.0301646.
Real-World Disease Burden and Healthcare Resource Utilization Among Patients with COPD and Asthma Using Triple Therapy (FF/UMEC/VI) in the United States.
Igboekwe E, Verma S, Paczkowski R
Int J Chron Obstruct Pulmon Dis. 2024; 19:281-296.
PMID: 38292138
PMC: 10824610.
DOI: 10.2147/COPD.S423993.
Hospitalized acute exacerbation in chronic obstructive pulmonary disease - impact on long-term renal outcomes.
Kwok W, Tam T, Ho J, Lam D, Ip M, Yap D
Respir Res. 2024; 25(1):36.
PMID: 38238804
PMC: 10797933.
DOI: 10.1186/s12931-023-02635-8.
The importance of the erythrocyte distribution width/albumin ratio in patients with chronic obstructive pulmonary disease exacerbation.
Eraslan B, Cengiz S, Sagmen S, Yalcinkaya K, Kiral N, Comert S
Saudi Med J. 2024; 45(1):27-33.
PMID: 38220226
PMC: 10807675.
DOI: 10.15537/smj.2024.45.1.20230716.
Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies.
Zhao Z, Lou O, Wang Y, Yin R, Gong C, Deng F
PLoS One. 2023; 18(12):e0296470.
PMID: 38157362
PMC: 10756550.
DOI: 10.1371/journal.pone.0296470.
Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review.
Qian Y, Cai C, Sun M, Lv D, Zhao Y
Int J Chron Obstruct Pulmon Dis. 2023; 18:2707-2723.
PMID: 38034468
PMC: 10683659.
DOI: 10.2147/COPD.S433183.
Effect on muscle strength after blood flow restriction resistance exercise in early in-patient rehabilitation of post-chronic obstructive pulmonary disease acute exacerbation, a single blinded, randomized controlled study.
Lau C, Leung S, Wah S, Yip C, Wong W, Chan K
Chron Respir Dis. 2023; 20:14799731231211845.
PMID: 37976375
PMC: 10657539.
DOI: 10.1177/14799731231211845.
Guideline-discordant inhaler regimens after COPD hospitalization: associations with rurality, drive time to care, and fragmented care - a United States cohort study.
Baldomero A, Kunisaki K, Wendt C, Henning-Smith C, Hagedorn H, Bangerter A
Lancet Reg Health Am. 2023; 26:100597.
PMID: 37766800
PMC: 10520452.
DOI: 10.1016/j.lana.2023.100597.
Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?.
Wang J, Gan Q, Zhang H, Xing Q, Wu Y, Su X
Am J Respir Crit Care Med. 2023; 208(10):1143-1144.
PMID: 37734069
PMC: 10867923.
DOI: 10.1164/rccm.202307-1301LE.